Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- Author
- PRADOS, Michael D1 ; CHANG, Susan M1 ; FEDOROFF, Anne1 ; SNEED, Penny K1 ; BERGER, Mitchel S1 ; MCDERMOTT, Michael W1 ; PARSA, Andrew T1 ; VANDENBERG, Scott1 ; JAMES, C. David1 ; LAMBORN, Kathleen R1 ; STOKOE, David1 ; HAAS-KOGAN, Daphne A1 ; BUTOWSKI, Nicholas1 ; DEBOER, Rebecca1 ; PARVATANENI, Rupa1 ; CARLINER, Hannah1 ; KABUUBI, Paul1 ; AYERS-RINGLER, Jennifer1 ; RABBITT, Jane1 ; PAGE, Margaretta1
[1] University of California, San Francisco, Comprehensive Cancer Center, San Francisco, CA, United States - Source
Journal of clinical oncology. 2009, Vol 27, Num 4, pp 579-584, 6 p ; ref : 18 ref
- ISSN
- 0732-183X
- Scientific domain
- Medical oncology
- Publisher
- American Society of Clinical Oncology, Alexandria, VA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Cancérologie Erlotinib Essai clinique phase II Glioblastome multiforme Gliosarcome Homme Radiothérapie Sarcome Stade précoce Traitement Témozolomide Agent alkylant Cancer Dérivé de la quinazoline Enzyme Gliome malin Inhibiteur de la tyrosine kinase Inhibiteur enzyme Pathologie du système nerveux central Pathologie du système nerveux Protein-tyrosine kinase Transferases Tumeur maligne
- Keyword (en)
- Antineoplastic agent Cancerology Erlotinib Phase II trial Glioblastoma multiforme Gliosarcoma Human Radiotherapy Sarcoma Early stage Treatment Temozolomide Alkylating agent Cancer Quinazoline derivatives Enzyme Malignant glioma Tyrosine kinase inhibitor Enzyme inhibitor Central nervous system disease Nervous system diseases Protein-tyrosine kinase Transferases Malignant tumor
- Keyword (es)
- Anticanceroso Cancerología Erlotinib Ensayo clínico fase II Glioblastoma multiforme Gliosarcoma Hombre Radioterapia Sarcoma Estadio precoz Tratamiento Temozolomida Agente alquilante Cáncer Enzima Glioma maligno Inhibidor tyrosine kinase Inhibidor enzima Sistema nervosio central patología Sistema nervioso patología Protein-tyrosine kinase Transferases Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17E Tumors of the nervous system. Phacomatoses
- Discipline
- Neurology Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21178001
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1200/JCO.2008.18.9639 
https://dx.doi.org/10.1200/JCO.2008.18.9639
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2008.18.9639\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"584\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PRADOS\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"CHANG, Susan M\";i:1;s:14:\"FEDOROFF, Anne\";i:2;s:14:\"SNEED, Penny K\";i:3;s:17:\"BERGER, Mitchel S\";i:4;s:20:\"MCDERMOTT, Michael W\";i:5;s:15:\"PARSA, Andrew T\";i:6;s:17:\"VANDENBERG, Scott\";i:7;s:15:\"JAMES, C. David\";i:8;s:19:\"LAMBORN, Kathleen R\";i:9;s:13:\"STOKOE, David\";i:10;s:20:\"HAAS-KOGAN, Daphne A\";i:11;s:18:\"BUTOWSKI, Nicholas\";i:12;s:15:\"DEBOER, Rebecca\";i:13;s:17:\"PARVATANENI, Rupa\";i:14;s:16:\"CARLINER, Hannah\";i:15;s:13:\"KABUUBI, Paul\";i:16;s:23:\"AYERS-RINGLER, Jennifer\";i:17;s:13:\"RABBITT, Jane\";i:18;s:16:\"PAGE, Margaretta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2008.18.9639\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"584\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PRADOS\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"CHANG, Susan M\";i:1;s:14:\"FEDOROFF, Anne\";i:2;s:14:\"SNEED, Penny K\";i:3;s:17:\"BERGER, Mitchel S\";i:4;s:20:\"MCDERMOTT, Michael W\";i:5;s:15:\"PARSA, Andrew T\";i:6;s:17:\"VANDENBERG, Scott\";i:7;s:15:\"JAMES, C. David\";i:8;s:19:\"LAMBORN, Kathleen R\";i:9;s:13:\"STOKOE, David\";i:10;s:20:\"HAAS-KOGAN, Daphne A\";i:11;s:18:\"BUTOWSKI, Nicholas\";i:12;s:15:\"DEBOER, Rebecca\";i:13;s:17:\"PARVATANENI, Rupa\";i:14;s:16:\"CARLINER, Hannah\";i:15;s:13:\"KABUUBI, Paul\";i:16;s:23:\"AYERS-RINGLER, Jennifer\";i:17;s:13:\"RABBITT, Jane\";i:18;s:16:\"PAGE, Margaretta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2008.18.9639\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2008.18.9639\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"584\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PRADOS\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"CHANG, Susan M\";i:1;s:14:\"FEDOROFF, Anne\";i:2;s:14:\"SNEED, Penny K\";i:3;s:17:\"BERGER, Mitchel S\";i:4;s:20:\"MCDERMOTT, Michael W\";i:5;s:15:\"PARSA, Andrew T\";i:6;s:17:\"VANDENBERG, Scott\";i:7;s:15:\"JAMES, C. David\";i:8;s:19:\"LAMBORN, Kathleen R\";i:9;s:13:\"STOKOE, David\";i:10;s:20:\"HAAS-KOGAN, Daphne A\";i:11;s:18:\"BUTOWSKI, Nicholas\";i:12;s:15:\"DEBOER, Rebecca\";i:13;s:17:\"PARVATANENI, Rupa\";i:14;s:16:\"CARLINER, Hannah\";i:15;s:13:\"KABUUBI, Paul\";i:16;s:23:\"AYERS-RINGLER, Jennifer\";i:17;s:13:\"RABBITT, Jane\";i:18;s:16:\"PAGE, Margaretta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2008.18.9639\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"584\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PRADOS\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"CHANG, Susan M\";i:1;s:14:\"FEDOROFF, Anne\";i:2;s:14:\"SNEED, Penny K\";i:3;s:17:\"BERGER, Mitchel S\";i:4;s:20:\"MCDERMOTT, Michael W\";i:5;s:15:\"PARSA, Andrew T\";i:6;s:17:\"VANDENBERG, Scott\";i:7;s:15:\"JAMES, C. David\";i:8;s:19:\"LAMBORN, Kathleen R\";i:9;s:13:\"STOKOE, David\";i:10;s:20:\"HAAS-KOGAN, Daphne A\";i:11;s:18:\"BUTOWSKI, Nicholas\";i:12;s:15:\"DEBOER, Rebecca\";i:13;s:17:\"PARVATANENI, Rupa\";i:14;s:16:\"CARLINER, Hannah\";i:15;s:13:\"KABUUBI, Paul\";i:16;s:23:\"AYERS-RINGLER, Jennifer\";i:17;s:13:\"RABBITT, Jane\";i:18;s:16:\"PAGE, Margaretta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:24:\"10.1200\/JCO.2008.18.9639\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Journal of clinical oncology\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. clin. oncol\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"27\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"579\";s:8:\"\u0000*\u0000epage\";s:3:\"584\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0732-183X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PRADOS\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:14:\"CHANG, Susan M\";i:1;s:14:\"FEDOROFF, Anne\";i:2;s:14:\"SNEED, Penny K\";i:3;s:17:\"BERGER, Mitchel S\";i:4;s:20:\"MCDERMOTT, Michael W\";i:5;s:15:\"PARSA, Andrew T\";i:6;s:17:\"VANDENBERG, Scott\";i:7;s:15:\"JAMES, C. David\";i:8;s:19:\"LAMBORN, Kathleen R\";i:9;s:13:\"STOKOE, David\";i:10;s:20:\"HAAS-KOGAN, Daphne A\";i:11;s:18:\"BUTOWSKI, Nicholas\";i:12;s:15:\"DEBOER, Rebecca\";i:13;s:17:\"PARVATANENI, Rupa\";i:14;s:16:\"CARLINER, Hannah\";i:15;s:13:\"KABUUBI, Paul\";i:16;s:23:\"AYERS-RINGLER, Jennifer\";i:17;s:13:\"RABBITT, Jane\";i:18;s:16:\"PAGE, Margaretta\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:152:\"Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:37:\"American Society of Clinical Oncology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
